Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/ijms23031441
Keywords
transcriptomics; proteomics; alternative splicing; alternative polyadenylation; expanded CUG repeats; gene expression; therapies; myotonic dystrophy; RNA-binding proteins; RNA metabolism
Funding
- Generalitat Valenciana [PROMETEO/2020/081]
- la Caixa Banking Foundation [HR17-00268]
- Conselleria for Education, Research, Culture, and Sport [Grisoliap2018/098]
Ask authors/readers for more resources
Omics studies are crucial for understanding DM1, revealing various changes in gene and microRNA expression, alternative splicing, 3 ' polyadenylation, CpG methylation, and protein levels. Moreover, omics characterization of drug treatment experiments provides insights into therapeutic rescue and off-target effects. Innovative technologies like single-cell sequencing and AI will have a significant impact on future DM1 research.
Omics studies are crucial to improve our understanding of myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults. Employing tissue samples and cell lines derived from patients and animal models, omics approaches have revealed the myriad alterations in gene and microRNA expression, alternative splicing, 3 ' polyadenylation, CpG methylation, and proteins levels, among others, that contribute to this complex multisystem disease. In addition, omics characterization of drug candidate treatment experiments provides crucial insight into the degree of therapeutic rescue and off-target effects that can be achieved. Finally, several innovative technologies such as single-cell sequencing and artificial intelligence will have a significant impact on future DM1 research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available